SPERLING SCOTT M 4

What Happened

• Scott M. Sperling, a director of Thermo Fisher Scientific (TMO), received a grant/award of 499 shares reported on a Form 4 for the 2026-05-20 transaction date. The filing records the acquisition price as $0.00, which indicates a director compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-20; Form 4 filed: 2026-05-22.
• Transaction type: Award/Grant (code A) — 499 shares acquired at $0.00 per share.
• Total reported purchase value on the form: $0 (grant reported as $0.00).
• Shares owned after the transaction: not specified in the provided filing details.
• No footnotes, 10b5-1 plan, or tax-withholding details were included in the provided transaction record.
• Filing timeliness: Form filed two days after the transaction date (no late-filing flag provided).

Context

• Awards to directors are commonly part of board compensation (restricted stock units or similar) and typically vest over time; the $0.00 reporting reflects a grant, not a zero-dollar economic transfer — the actual value depends on Thermo Fisher’s market price and vesting terms. Such grants are routine and do not by themselves signal the insider’s view on the stock.